This article is more than 5 years old. Information may no longer be current.

Medtech receives marketing authorization in Australia for robotic surgery system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Medtech recently announced it has received official authorization to market its ROSA robot in Australia for minimally invasive surgical procedures on the brain, as well as for spine surgery.

The company also announced it has signed a contract for distribution in Australia and New Zealand with Surgicom, a company specializing in the distribution of medical devices, according to a company press release.

The agreement reinforces Medtech’s geographical coverage in the Asia-Pacific region through Surgicom’s various offices and commercial agents in Sydney, Melbourne, Adelaide, Perth and Auckland, according to the release.

The ROSA robot is a technological device devoted to brain surgery procedures. ROSA has been approved in Europe, the United States and Canada, the release stated.

Reference: www.medtech.org.